Chemoinformaics analysis of n-Caffeoyltyramine
| Molecular Weight | 299.326 | nRot | 5 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 14 |
| Exact Molecular Weight | 299.116 | nRing | 2 |
| Solubility: LogS | -2.86 | nHRing | 0 |
| Solubility: LogP | 2.318 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 44.0335 |
| nHD | 4 | BPOL | 18.4925 |
| QED | 0.503 |
| Synth | 2.061 |
| Natural Product Likeliness | 0.414 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.025 |
| Pgp-sub | 0.04 |
| HIA | 0.046 |
| CACO-2 | -5.009 |
| MDCK | 0.0000122 |
| BBB | 0.043 |
| PPB | 0.965898 |
| VDSS | 0.566 |
| FU | 0.0267765 |
| CYP1A2-inh | 0.713 |
| CYP1A2-sub | 0.093 |
| CYP2c19-inh | 0.503 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.727 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.67 |
| CYP2d6-sub | 0.882 |
| CYP3a4-inh | 0.661 |
| CYP3a4-sub | 0.191 |
| CL | 16.205 |
| T12 | 0.926 |
| hERG | 0.119 |
| Ames | 0.386 |
| ROA | 0.56 |
| SkinSen | 0.954 |
| Carcinogencity | 0.411 |
| EI | 0.298 |
| Respiratory | 0.187 |
| NR-Aromatase | 0.33 |
| Antiviral | Yes |
| Prediction | 0.689942 |